Correlation Between Dominari Holdings and GT Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and GT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and GT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dominari Holdings and GT Biopharma, you can compare the effects of market volatilities on Dominari Holdings and GT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of GT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and GT Biopharma.

Diversification Opportunities for Dominari Holdings and GT Biopharma

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Dominari and GTBP is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and GT Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GT Biopharma and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with GT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GT Biopharma has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and GT Biopharma go up and down completely randomly.

Pair Corralation between Dominari Holdings and GT Biopharma

Given the investment horizon of 90 days Dominari Holdings is expected to generate 0.89 times more return on investment than GT Biopharma. However, Dominari Holdings is 1.12 times less risky than GT Biopharma. It trades about 0.03 of its potential returns per unit of risk. GT Biopharma is currently generating about -0.07 per unit of risk. If you would invest  169.00  in Dominari Holdings on September 4, 2024 and sell it today you would earn a total of  2.00  from holding Dominari Holdings or generate 1.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dominari Holdings  vs.  GT Biopharma

 Performance 
       Timeline  
Dominari Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dominari Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong primary indicators, Dominari Holdings is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
GT Biopharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in GT Biopharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting fundamental drivers, GT Biopharma reported solid returns over the last few months and may actually be approaching a breakup point.

Dominari Holdings and GT Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dominari Holdings and GT Biopharma

The main advantage of trading using opposite Dominari Holdings and GT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, GT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GT Biopharma will offset losses from the drop in GT Biopharma's long position.
The idea behind Dominari Holdings and GT Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios